Axel Benner Selected Research

ProBase

1/2022

A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Axel Benner Research Topics

Disease

70	Neoplasms (Cancer) 01/2022 - 01/2003
23	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2003
19	Multiple Myeloma 01/2022 - 11/2002
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2004
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 08/2002
13	Neoplasm Metastasis (Metastasis) 11/2018 - 01/2004
10	Breast Neoplasms (Breast Cancer) 10/2013 - 11/2003
9	Melanoma (Melanoma, Malignant) 01/2018 - 02/2002
9	Neuroblastoma 01/2016 - 01/2006
9	Medulloblastoma 04/2012 - 05/2004
8	Immunoglobulin Light-chain Amyloidosis 10/2021 - 03/2014
6	Amyloidosis 01/2021 - 05/2008
6	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2020 - 06/2003
6	Carcinogenesis 01/2020 - 11/2003
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2016 - 05/2008
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 04/2013
4	Leukemia 01/2018 - 05/2008
4	Colonic Neoplasms (Colon Cancer) 03/2016 - 09/2005
4	Ependymoma 11/2012 - 04/2006
4	Carcinoma (Carcinomatosis) 10/2012 - 01/2004
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2009 - 10/2004
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2009 - 10/2003
3	Inflammation (Inflammations) 04/2022 - 11/2007
3	Lung Neoplasms (Lung Cancer) 04/2022 - 12/2015
3	Renal Insufficiency (Renal Failure) 01/2019 - 11/2006
3	Infections 01/2019 - 01/2007
3	Brain Neoplasms (Brain Tumor) 03/2009 - 11/2007
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009 - 10/2004
2	Chromothripsis 01/2022 - 01/2017
2	Genomic Instability 01/2022 - 01/2021
2	Adenocarcinoma 01/2020 - 09/2003
2	Paraproteinemias (Monoclonal Gammopathy) 01/2020 - 05/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2016
2	Trisomy (Trisomies) 01/2018 - 04/2010
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2016 - 06/2012
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 10/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2015 - 10/2004
2	Weight Loss (Weight Reduction) 10/2015 - 05/2015

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2003
20	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2002
15	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2004
12	Messenger RNA (mRNA)IBA 01/2016 - 11/2003
10	Biological ProductsIBA 01/2020 - 08/2002
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 07/2010
9	Pharmaceutical PreparationsIBA 01/2022 - 12/2006
8	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 11/2006
8	MicroRNAs (MicroRNA)IBA 01/2017 - 12/2011
7	Rituximab (Mabthera)FDA Link 01/2022 - 10/2004
5	Peptides (Polypeptides)IBA 01/2020 - 04/2008
5	Phosphotransferases (Kinase)IBA 01/2018 - 01/2004
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2016 - 01/2009
4	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2017
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022 - 02/2006
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2004
4	SteroidsIBA 11/2020 - 08/2011
4	3' Untranslated Regions (3' UTR)IBA 11/2018 - 09/2005
4	CytokinesIBA 01/2018 - 12/2011
4	AntigensIBA 01/2018 - 02/2015
4	RNA (Ribonucleic Acid)IBA 10/2012 - 11/2003
4	Complementary DNA (cDNA)IBA 08/2007 - 08/2004
3	fludarabineIBA 01/2022 - 10/2004
3	Gemtuzumab (Mylotarg)FDA Link 11/2021 - 01/2016
3	Calcibiotic Root Canal SealerIBA 10/2021 - 07/2007
3	Bortezomib (Velcade)FDA Link 10/2021 - 04/2015
3	ParaffinIBA 10/2021 - 01/2012
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2021 - 06/2007
3	Core Binding Factors (Core-Binding Factor)IBA 12/2020 - 01/2017
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 05/2015
3	Fluorouracil (Carac)FDA LinkGeneric 07/2018 - 12/2015
3	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 08/2002
3	Proto-Oncogene Proteins B-rafIBA 10/2005 - 01/2004
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2005 - 01/2004
2	Genetic Markers (Genetic Marker)IBA 01/2022 - 01/2017
2	midostaurinIBA 01/2022 - 01/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 05/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 06/2016
2	Formaldehyde (Formol)FDA Link 10/2021 - 01/2012
2	daratumumabIBA 01/2021 - 01/2020
2	AntibodiesIBA 01/2021 - 01/2018
2	AlbuminsIBA 01/2020 - 05/2015
2	HLA-A Antigens (HLA-A)IBA 01/2020 - 07/2005
2	Long Noncoding RNAIBA 01/2020 - 04/2013
2	VaccinesIBA 01/2020 - 01/2018
2	Immunomodulating AgentsIBA 01/2019 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 03/2016 - 12/2011
2	malate dehydrogenase (decarboxylating)IBA 03/2016 - 01/2008
2	Differentiation AntigensIBA 02/2016 - 02/2002
2	Histocompatibility Antigens Class IIBA 02/2016 - 07/2005
2	Complement System Proteins (Complement)IBA 04/2013 - 07/2010

Therapy/Procedure

37	Therapeutics 01/2022 - 11/2003
23	Drug Therapy (Chemotherapy) 01/2022 - 05/2004
17	Stem Cell Transplantation 07/2021 - 06/2003
6	Transplantation 01/2018 - 09/2004
5	Radiotherapy 03/2016 - 11/2003
3	Adjuvant Chemotherapy 01/2022 - 09/2005
3	Immunotherapy 01/2021 - 02/2002
3	Salvage Therapy 01/2020 - 07/2013
3	Autologous Transplantation 01/2016 - 09/2004
2	Cell Transplantation 01/2022 - 01/2016
2	Heterologous Transplantation (Xenotransplantation) 02/2016 - 01/2016